Health Insider

Medicare Drug Negotiations, Medicare Advantage In Spotlight This Week

By Amy Lotven, Bridget Early, Dorothy Mills-Gregg / January 29, 2024 at 8:59 PM

The fate of Medicare drug price negotiations will come closer into view this week as the first of many oral arguments in the drug industry’s challenge to the Inflation Reduction Act are set for Wednesday -- one day ahead of CMS’ deadline for setting the initial offer of a maximum fair price to the manufacturers of the 10 selected Medicare drugs.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Health Insider

Medicare Drug Negotiations, Medicare Advantage In Spotlight This Week

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.